Concert Pharmaceuticals, Inc.
Morphinan Compounds

Last updated:

Abstract:

This disclosure relates to novel morphinan compounds and their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This disclosure also provides compositions comprising a compound of this disclosure and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a al receptor agonist that also has NMDA antagonist activity.

Status:
Application
Type:

Utility

Filling date:

14 Dec 2020

Issue date:

11 Nov 2021